"Like so many others, my family has been afflicted by cancer. It was my grandpa, who died from lung cancer, who started me on this journey."
In a Q&A, Jacob (Jake) New of @ScrippsRTI shares how he’s advancing targeted cancer therapies by translating lab discoveries into personalized patient care. More: https://t.co/YVch4AKqm0
Using data from consumer wearables, researchers at @ScrippsRTI report in @JMIR_ an association between night-to-night sleep variability and increased risk of obstructive sleep apnea and hypertension, highlighting the potential of wearables for identifying sleep-related cardiovascular risk. More: https://t.co/SNyCi2EJ07
The Long COVID Treatment Trial – Tirzepatide (LoCITT-T) is officially open for enrollment for people with Long COVID in:
Alabama, Alaska, California, Florida, Illinois, Indiana, Michigan, Ohio, Pennsylvania, Texas, Utah
https://t.co/K7yjhCfV3N
1/16
Join the Long COVID Treatment Trial team for a live webinar to learn about upcoming clinical trials designed to advance Long COVID research. Aug 26 | 2pm EST/11am PST. Registration required. https://t.co/uGzec95x1W
Join the Long COVID Treatment Trial team for a live webinar to learn about upcoming clinical trials designed to advance Long COVID research. Aug 26 | 2pm EST/11am PST. Registration required. https://t.co/uGzec95x1W
Scientists at @ScrippsDTC describe an AI model that can detect hidden diabetes risk by analyzing data from continuous glucose monitors, alongside gut microbiome, diet, physical activity and genetic information. @NatureMedicine https://t.co/ZtQzrrQrTu
The future of personalized medicine is a lot closer than you think! ⌚️💊
At the Scripps Research Digital Trials Center (@ScrippsDTC), scientists are reimagining how clinical studies are done, using wearable devices, smartphone apps, and at-home biosample kits to gather data on sleep, genetics, glucose levels and more, all without the need for a clinic visit.
Following a Front Row lecture with Eric Topol, MD (@EricTopol), executive vice president of Scripps Research and director of the Translational Institute (@ScrippsRTI), guests had the opportunity to explore translational research firsthand at #ScienceinAction.
Inspired by his new book Super Agers, Topol’s talk highlighted how AI and biomedical breakthroughs are transforming our approach to aging and chronic disease.
To see Science in Action in person, join us on Wednesday, August 20, at 4 p.m. PT for our next Front Row lecture: “Reprogramming the immune system: A new era of precision immunotherapy for cancer and autoimmune disease,” featuring Calibr‑Skaggs’ vice president of biologics, Travis Young (@CARTCellTherapy), PhD.
After his talk, guests can step outside for Science in Action, and meet scientists from Calibr-Skaggs, take part in hands‑on demos, see the tools used in research, and get answers to questions sparked by the lecture.
Register now: https://t.co/PtfckwZclD
🚨 Long COVID patients 🚨Our team is working with the Schmidt Initiative for Long COVID and @careevolution to launch a clinical trial to investigate the efficacy of a repurposed drug for treating Long COVID. Learn more and sign up for notifications. https://t.co/M7z6RxXqtM
Thanks to @SDSU for hosting yesterday’s Perspectives in STEM seminar and networking event where we learned about the importance of collaboration, communication and mentorship when pursuing careers in academia and industry.
Here is the final version of our research demonstrating that providing at-home COVID-19 tests, along with on-demand telemedicine and rapid prescription delivery can reduce COVID ICU stays in immunocompromised people (more info at bsky)
https://t.co/sazZQ4l6H5
Interested in STEM and want to learn about collaboration between academic institutes and industry? Join us at @SDSU on June 3 for a networking event and seminar. Find out more and register at - https://t.co/SQBgLKru2K
Ali Torkamani joined @KUSINews this morning to discuss his latest @NatureMedicine study on a better way to predict a patient’s risk of coronary artery disease using #AI. https://t.co/zT8fNIUx5P
Our @Nature paper today on multimodal generative #AI for interpretation of medical images and generating reports across many specialties https://t.co/zsnZj7U20t
@pranavrajpurkar@VishRao5
A Q&A with @julialmv on her long COVID journey and what she would do if she was appointed the national long COVID czar. @sdut@PaulSisson https://t.co/9BiuZZanBn